Reversible splenial lesion syndrome in children: Retrospective study and summary of case series

Wen-Xiong Chen1, Hong-Sheng Liu2, Si-Da Yang1

  • 1Department of Neurology, Brain Center, Guangzhou Women and Children's Medical Center, Affiliated Guangzhou Medical University, Guangzhou City, Guangdong Province, China.

Brain & Development
|September 4, 2016
PubMed

Insights

Reversible splenial lesion syndrome (RESLES) in children typically resolves well, but severe cases, particularly those with extra-corpus callosum lesions, may lead to lasting neurological issues like intellectual disability.

Area of Science:

  • Pediatric Neurology
  • Neuroimaging
  • Infectious Diseases

Background:

  • Reversible splenial lesion syndrome (RESLES) is a rare neurological condition.
  • Mild encephalitis/encephalopathy with a reversible splenial lesion (MERS) is a subtype of RESLES.

Purpose of the Study:

  • To detail the clinical characteristics of RESLES in pediatric patients.
  • To compare severe versus non-severe RESLES cases and identify prognostic factors.

Main Methods:

  • Retrospective analysis of 16 RESLES episodes in 15 children.
  • Comparison of clinical and radiological features between severe and non-severe RESLES groups.
  • Summary of five pediatric MERS case series.

Main Results:

  • Common neurological symptoms included seizures, behavioral changes, and altered consciousness.
  • Splenial lesions (SCC, extra-SCC, extra-CC) showed characteristic MRI findings.
  • Most patients recovered fully, but severe cases with extra-CC lesions had a higher risk of neurological sequelae, including intellectual disability.

Conclusions:

  • RESLES in children generally has a favorable prognosis.
  • Severe RESLES, especially with extra-corpus callosum lesions, warrants closer monitoring due to potential for neurological sequelae.
Abstract

Related Concept Videos